Publication not explained
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
Read the Original
This page is a summary of: Effect of galectin-3 inhibition on drug resistance, motility, invasion, and angiogenic potential in ovarian cancer., Journal of Clinical Oncology, May 2014, American Society of Clinical Oncology (ASCO), DOI: 10.1200/jco.2014.32.15_suppl.e22005.
You can read the full text:
The following have contributed to this page